We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,630,000 ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non ...